Forma Therapeutics Garners $25,500,000 Series B Funding Round

  • Feed Type
  • Date
    12/1/2009
  • Company Name
    Forma Therapeutics
  • Mailing Address
    790 Memorial Drive Cambridge, MA 02139
  • Company Description
    FORMA Therapeutics is a biopharmaceutical company integrating transformative biology and chemistry to unlock targets and pathways that have been validated through genomic medicine as root causes or major drivers of human cancers.
  • Website
    http://www.formatherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $25,500,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    “With this new funding, FORMA will focus on advancing our internal target-based oncology programs and in parallel, we will continue to pursue non-dilutive collaborations to further build our integrated drug discovery platform,” said Steven Tregay, CEO of FORMA.
  • M&A Terms
  • Venture Investor
    Lilly Ventures
  • Venture Investor
    Novartis Venture Fund
  • Venture Investor
    Bio*One Capital

By posting a comment, you agree to our terms and conditions.